BeOne Medicines Honored with the Global Oncology Innovation Leadership Award at BIOHK 2025, Supporting "1+" to Accelerate the Delivery of Innovative Cancer Therapies

HONG KONG SAR - Media OutReach Newswire - 11 September 2025 - BeOne Medicines (BeOne)(NASDAQ: ONC; HKEX: 06160; SSE: 688235), was honored today at BIOHK 2025, the Hong Kong International Biotechnology Conference & Exhibition, with the prestigious Global Oncology Innovation Leadership Award.